431-440 of 557 results

Dealing with data: emerging trends in M&A transactions
Insight 27 Nov 2019

Data remains one of the most undervalued assets, with most companies still failing to even include it as an asset on their balance sheet. Buyers and sellers who can recognise data assets and properly demonstrate how value can be extracted from them will be best placed for future M&A transactions. ...

TGA guidance on the promotion of medicinal cannabis
Insight 24 Nov 2019

The Therapeutic Goods Administration (TGA) has issued guidance on advertising to the public for businesses involved with medicinal cannabis products and therapies. Along with advertising restrictions, ...

The rise of plant-based 'meats' and emerging legal issues
Insight 11 Dec 2019

The demand for plant-based 'meat' alternatives is predicted to grow. As with any new industry, there is a series of regulatory issues that businesses should carefully navigate at the early planning phase. This is to avoid encountering issues down the track that may affect the marketing and supply of such products in Australia. ...

Healthcare trend watch 2019
Insight 09 Dec 2019

The healthcare team at Allens reports on some key trends and sectors to look out for in 2020. ...

TGA guidance on the promotion of stem cells and HCT products
Insight 09 Dec 2019

The Therapeutic Goods Administration has issued advertising guidance for businesses involved with stems cells and other human cell or tissue products. ...

E-signature - a case study, but not a test case
Insight 29 Sep 2016

A recent New South Wales Court of Appeal decision concerned a guarantee purportedly signed by e-signature without the guarantors knowledge It is an interesting case-study though the decision is really about ostensible authority and ratification Senior Finance Counsel Diccon Loxton considers its ...

Protecting investment in biologic medicines - biological medicines, biosimilars and the challenges they pose
Insight 15 Sep 2016

This series of articles is directed towards the part of biotech that is pharmaceutical rather than diagnostic or bioengineering technologies and in particular towards biologic medicines ...

Unexpected risks of the IoT revolution: Cyber security in medical devices
Insight 16 Oct 2017

In late August 2017 the US Food and Drug Administration recalled 465000 Abbott Laboratories pacemakers due to cyber security vulnerabilities Although this was the first time that the FDA had recalled a medical device because of cyber concerns they have been alive to the significant risk that a cyber ...

Flame's copyright claim success a 'dark horse'
Insight 28 Aug 2019

Christian rapper Flame has succeeded in a copyright infringement claim against Katy Perry regarding her single 'Dark Horse', in what some are viewing as an overreach of copyright protection. ...

Refine